Risk‐reducing medications for primary breast cancer: a network meta‐analysis – Cochrane Library (free)
Related Commentary on Twitter
New @CochraneBCancer Review – Risk-reducing medications for primary breast cancer https://t.co/NOidQ4HrhV 6 studies enrolling 50,927 women. Specialized method, network meta‐analysis, allowed comparison of medications never directly compared to each other in a study.
— The Cochrane Library (@CochraneLibrary) April 30, 2019